{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:45:35Z","timestamp":1760820335346},"reference-count":19,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1546,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1600-0404.2011.01536.x","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T09:20:41Z","timestamp":1307524841000},"page":"417-423","source":"Crossref","is-referenced-by-count":9,"title":["Tetracycline treatment in patients with progressive external ophthalmoplegia"],"prefix":"10.1155","volume":"124","author":[{"given":"M.","family":"Mancuso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Orsucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Calsolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"LoGerfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Allegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Petrozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Trivella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Murri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"Dimauro","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00415-009-5409-7","article-title":"Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation","volume":"257","author":"Mancuso","year":"2010","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB4|cit4","article-title":"Treatment for mitochondrial disorders","author":"Chinnery","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/01.wnl.0000258659.21421.b0","article-title":"Tetracycline delays ocular motility decline in chronic progressive external ophthalmoplegia","volume":"68","author":"Omar","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","article-title":"The Italian SF-36 Health Survey: translation, validation and norming","volume":"51","author":"Apolone","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/01.wnl.0000219759.72195.41","article-title":"Mitochondrial disease in adults: a scale to monitor progression and treatment","volume":"66","author":"Schaefer","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB9|cit9","volume-title":"Binocular Vision and Ocular Motility","author":"Von Noorden","year":"2002"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/187152709788680689","article-title":"Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease","volume":"8","author":"Orsucci","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: an open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm1242","article-title":"Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice","volume":"11","author":"Davies","year":"2005","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.21523","article-title":"Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy","volume":"65","author":"Girgenrath","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcp.21306","article-title":"Exercise running and tetracycline as means to enhance skeletal muscle stem cell performance after external fixation","volume":"215","author":"Shefer","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1600-0404.2011.01536.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nbd.2007.07.021","article-title":"Minocycline, a possible neuroprotective agent in Leber\u2019s hereditary optic neuropathy (LHON): studies of cybrid cells bearing 11,778 mutation","volume":"28","author":"Haroon","year":"2007","journal-title":"Neurobiol Dis"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2011.01536.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2011.01536.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:49:37Z","timestamp":1671540577000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2011.01536.x"}},"subtitle":["Tetracycline treatment in PEO"],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01536.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,8]]}}}